• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长非编码 RNA X91348 在肝细胞癌中的表达水平及临床意义。

The expression level and clinical significance of lncRNA X91348 in hepatocellular carcinoma.

机构信息

a Comprehensive Liver Cancer Center, 5th Medical Center of Chinese PLA General Hospital , Beijing , PR China.

b Radiology Department, 5th Medical Center of Chinese PLA General Hospital , Beijing , PR China.

出版信息

Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):3067-3071. doi: 10.1080/21691401.2019.1640228.

DOI:10.1080/21691401.2019.1640228
PMID:31349749
Abstract

Long non coding RNAs (lncRNAs) are important in the occurrence and development of various cancers. They have been considered to participate in many processes of diseases. In this study, we aimed at investigating expression level and clinical significance of lncRNA X91348 in hepatocellular carcinoma (HCC). The expression of X91348 in tissue and serum samples from patients with HCC and from healthy people was detected through quantitative real-time polymerase chain reaction (qRT-PCR). X91348 expression was decreased in patients with HCC compared with healthy controls no matter in tissue or serum samples. The relationship between X91348 expression and clinicopathologic characteristics was analysed. The result demonstrated that tumour size, HBsAg and Child-Pugh were vital influencing factors for X91348 expression, which revealed X91348 may be involved in the progress of HCC. Kaplan-Meier analysis was used to evaluate overall survival of patients with different expressions of X91348. Finally, prognostic value of X91348 in HCC was assessed cox regression analysis. X91348 was proved to be closely related to the prognosis of HCC. Taken together, the down-regulation of X91348 could be an independent diagnostic and prognostic indicator for HCC.

摘要

长链非编码 RNA(lncRNAs)在各种癌症的发生和发展中起着重要作用。它们被认为参与了疾病的许多过程。在这项研究中,我们旨在研究 lncRNA X91348 在肝细胞癌(HCC)中的表达水平和临床意义。通过定量实时聚合酶链反应(qRT-PCR)检测 HCC 患者和健康人组织和血清样本中的 X91348 表达。无论在组织还是血清样本中,与健康对照组相比,HCC 患者的 X91348 表达均降低。分析了 X91348 表达与临床病理特征的关系。结果表明,肿瘤大小、HBsAg 和 Child-Pugh 是 X91348 表达的重要影响因素,表明 X91348 可能参与了 HCC 的进展。Kaplan-Meier 分析用于评估不同 X91348 表达患者的总生存率。最后,通过 Cox 回归分析评估 X91348 在 HCC 中的预后价值。X91348 与 HCC 的预后密切相关。综上所述,X91348 的下调可能是 HCC 的一个独立诊断和预后指标。

相似文献

1
The expression level and clinical significance of lncRNA X91348 in hepatocellular carcinoma.长非编码 RNA X91348 在肝细胞癌中的表达水平及临床意义。
Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):3067-3071. doi: 10.1080/21691401.2019.1640228.
2
lncRNA-D16366 Is a Potential Biomarker for Diagnosis and Prognosis of Hepatocellular Carcinoma.lncRNA-D16366 是肝细胞癌诊断和预后的潜在生物标志物。
Med Sci Monit. 2019 Sep 2;25:6581-6586. doi: 10.12659/MSM.915100.
3
Serum long noncoding RNA urothelial carcinoma-associated 1: A novel biomarker for diagnosis and prognosis of hepatocellular carcinoma.血清长链非编码RNA尿路上皮癌相关1:一种用于肝细胞癌诊断和预后的新型生物标志物。
J Int Med Res. 2018 Jan;46(1):348-356. doi: 10.1177/0300060517726441. Epub 2017 Aug 31.
4
Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.长链非编码 RNA 标志物预测肝细胞癌无复发生存率。
World J Gastroenterol. 2019 Jan 14;25(2):220-232. doi: 10.3748/wjg.v25.i2.220.
5
Diagnostic and prognostic value of lncRNA cancer susceptibility candidate 9 in hepatocellular carcinoma.长链非编码 RNA 癌症易感性候选物 9 在肝细胞癌中的诊断和预后价值。
World J Gastroenterol. 2019 Dec 28;25(48):6902-6915. doi: 10.3748/wjg.v25.i48.6902.
6
Prognostic significance of long non-coding RNA PCAT-1 expression in human hepatocellular carcinoma.长链非编码RNA PCAT-1表达在人肝细胞癌中的预后意义
Int J Clin Exp Pathol. 2015 Apr 1;8(4):4126-31. eCollection 2015.
7
Down-Regulation of LncRNA DGCR5 Correlates with Poor Prognosis in Hepatocellular Carcinoma.长链非编码RNA DGCR5的下调与肝细胞癌的不良预后相关。
Cell Physiol Biochem. 2016;40(3-4):707-715. doi: 10.1159/000452582. Epub 2016 Nov 30.
8
Long noncoding RNA AWPPH promotes hepatocellular carcinoma progression through YBX1 and serves as a prognostic biomarker.长链非编码 RNA AWPPH 通过 YBX1 促进肝细胞癌进展,并作为一种预后生物标志物。
Biochim Biophys Acta Mol Basis Dis. 2017 Jul;1863(7):1805-1816. doi: 10.1016/j.bbadis.2017.04.014. Epub 2017 Apr 18.
9
Upregulation of Long Non-Coding RNA ENST00000429227.1 Is Correlated with Poor Prognosis in Human Hepatocellular Carcinoma.长链非编码 RNA ENST00000429227.1 的上调与肝癌患者的不良预后相关。
Med Sci Monit. 2019 Aug 31;25:6539-6546. doi: 10.12659/MSM.916551.
10
The long non-coding RNA AK001796 contributes to poor prognosis and tumor progression in hepatocellular carcinoma.长链非编码 RNA AK001796 促进肝癌的不良预后和肿瘤进展。
Eur Rev Med Pharmacol Sci. 2019 Mar;23(5):2013-2019. doi: 10.26355/eurrev_201903_17240.

引用本文的文献

1
Long non-coding RNA-based single and combination independent prognostic biomarkers for hepatocellular carcinoma.基于长链非编码RNA的肝细胞癌单因素及联合独立预后生物标志物
Discov Oncol. 2025 Sep 2;16(1):1674. doi: 10.1007/s12672-025-03309-1.
2
lncRNAs as Biomarkers of Hepatocellular Carcinoma Risk and Liver Damage in Advanced Chronic Hepatitis C.长链非编码RNA作为晚期慢性丙型肝炎肝细胞癌风险和肝损伤的生物标志物
Curr Issues Mol Biol. 2025 May 10;47(5):348. doi: 10.3390/cimb47050348.
3
Combinatorial Gene Expression Profiling of Serum , , and lncRNAs to Differentiate Hepatocellular Carcinoma from Liver Diseases: A Systematic Review and Meta-Analysis.
血清、[此处原文缺失两个逗号之间的内容]和长链非编码RNA的组合基因表达谱分析用于鉴别肝细胞癌与肝脏疾病:一项系统评价和Meta分析
Int J Mol Sci. 2024 Jan 19;25(2):1258. doi: 10.3390/ijms25021258.
4
A New Understanding of Long Non-Coding RNA in Hepatocellular Carcinoma-From mA Modification to Blood Biomarkers.长链非编码 RNA 在肝细胞癌中的新认识——从 mA 修饰到血液生物标志物。
Cells. 2023 Sep 14;12(18):2272. doi: 10.3390/cells12182272.
5
Long noncoding RNA MyD88 functions as a promising diagnostic biomarker in hepatocellular carcinoma.长链非编码 RNA MyD88 作为一种有前途的肝癌诊断生物标志物。
Front Endocrinol (Lausanne). 2023 Jan 30;14:938102. doi: 10.3389/fendo.2023.938102. eCollection 2023.
6
Non-coding RNAs in hepatocellular carcinoma: Insights into regulatory mechanisms, clinical significance, and therapeutic potential.非编码 RNA 在肝细胞癌中的作用:调控机制、临床意义及治疗潜能的深入探讨。
Front Immunol. 2022 Oct 10;13:985815. doi: 10.3389/fimmu.2022.985815. eCollection 2022.
7
lncRNA Expression-Based Risk Scoring System Can Predict Survival of Tumor-Positive Patients with Hepatocellular Carcinoma.基于 lncRNA 表达的风险评分系统可预测肝癌肿瘤阳性患者的生存情况。
Asian Pac J Cancer Prev. 2021 Dec 1;22(12):3741-3753. doi: 10.31557/APJCP.2021.22.12.3741.
8
Knockdown of long noncoding RNA colorectal neoplasia differentially expressed inhibits hepatocellular carcinoma progression by mediating the expression of nuclear autoantigenic sperm protein.长链非编码 RNA 结直肠肿瘤差异表达的敲低通过介导核自身抗原精子蛋白的表达抑制肝细胞癌进展。
Oncol Rep. 2021 Dec;46(6). doi: 10.3892/or.2021.8203. Epub 2021 Oct 11.
9
The Impact of Long Non-Coding RNAs in the Pathogenesis of Hepatocellular Carcinoma.长链非编码RNA在肝细胞癌发病机制中的作用
Front Oncol. 2021 Apr 21;11:649107. doi: 10.3389/fonc.2021.649107. eCollection 2021.
10
Lnc-ATG9B-4 aggravates progress of hepatocellular carcinoma through cell proliferation and migration by upregulating CDK5.Lnc-ATG9B-4 通过上调 CDK5 促进肝癌的进展,进而促进细胞增殖和迁移。
Exp Biol Med (Maywood). 2021 Jan;246(2):177-186. doi: 10.1177/1535370220963197. Epub 2020 Oct 6.